Related Experiment Videos
Calcium channel agonists and antagonists regulate protein phosphorylation in intact synaptosomes
Neuroscience Letters
|July 11, 1986
Summary
Calcium channel blockers like verapamil and nifedipine, and agonist BAY K 8644, increase basal phosphorylation of specific synaptosomal proteins. This suggests a novel mechanism of action for calcium channel-interacting drugs.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- Protein phosphorylation in synaptosomes is sensitive to calcium (Ca2+) fluxes.
- Calcium channel modulators are critical in neurological research and therapeutics.
Purpose of the Study:
- To investigate the mechanism of action of calcium channel agents BAY K 8644, verapamil, and nifedipine.
- To explore the impact of these agents on synaptosomal protein phosphorylation.
Main Methods:
- Intact synaptosomes were treated with calcium channel agonist BAY K 8644 and antagonists verapamil and nifedipine (1 microM).
- Basal and depolarization-dependent protein phosphorylation levels were analyzed.
- Protein kinase activity was assessed to rule out direct stimulation.
Main Results:
- All tested agents significantly increased basal phosphorylation of specific synaptosomal phosphoproteins (P139, P124, P96, P60).
- Depolarization-dependent protein phosphorylation remained unaltered by these agents.
- The observed increases in phosphorylation were not due to direct protein kinase stimulation.
Conclusions:
- Calcium channel modulators may exert effects through a novel mechanism involving basal protein phosphorylation.
- This finding suggests a potential new pathway for drugs interacting with calcium channels, distinct from their effects on neurotransmitter release.